Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Urolithiasis
Published in: Urolithiasis 6/2005

01-12-2005 | Original Paper

Analysis of urinary calculi obtained from a patient with idiopathic hypouricemia using micro area x-ray diffractometry and LC-MS

Authors: Kiyoko Kaneko, Tomoyo Yamanobe, Maki Onoda, Ken-ichi Mawatari, Kazuya Nakagomi, Shin Fujimori

Published in: Urolithiasis | Issue 6/2005

Login to get access

Abstract

Urolithiasis is a common complication in patients with hypouricemia. Using a microarea x-ray diffractometer and nanoflow liquid chromatography-mass spectrometry (LC-MS) following SDS-polyacrylamide gel electrophoresis (PAGE), recurrent urinary calculi complicating a hypouricemic patient were analyzed. Analysis with the microarea x-ray diffractometer showed that one of the calculi was composed of calcium oxalate monohydrate and hydroxyapatite. The other was found to be formed from calcium oxalate dihydrate. After determination with LC-MS, both were found to contain uromodulin, albumin, osteopontin, protein Z, and defensins. Lysozyme and calgranulin A were also identified in these calculi. Defensins, which were antimicrobial peptides, and lysozyme, a mucopeptide glycohydrolase, were identified as new organic components of urinary stones. The role of these proteins in the process of urolithiasis is of particular interest.
Literature
1.
Sperling O (1989) Hereditary renal hypouricemia. In: Scriver CR, Beaudet AL, Sly WS (eds) The metabolic basis of inherited disease, 6th edn. McGraw-Hill, New York, p 2605
2.
Binette J, Binette M, Gawinowicz M, Kendrick N (1996) Urinary stone proteins: an update.Scanning Microsc, 10: 509
3.
Siddiqu A, Sultana T, Buchhols NP, Waqar M, Talati J (1998) Protein in renal stones and urine of stone formers. Urol Res 2: 6383
4.
Kohri K, Nomura S, Kitamura Y, Nagata T, Yoshioka TK, Iguchi M, Yamate T, Umekawa TT, Suzuki Y, Sinohara H, Kurita T (1993) Structure and expression of the mRNA encoding urinary stone protein (osteopontin). J Biol Chem 268: 15180PubMed
5.
Yamate T, Umekawa T, Iguchi M, Kurita T, Kohri K (1997) Detection of osteopontin as matrix protein in calcium-containing urinary stones. Acta Urol Jpn 43: 623
6.
Grover P, Stapletpn A, Ryall R (1999) Prothrombin gene expression in rat kidneys provides an opportunity to examine its role in urinary stone. J Am Soc Nephrol 10: S404PubMed
7.
Nishio S, Hatanaka M, Takeda H, Aoki K, Iseda T, Iwata H, Yokoyama M (2000) Calcium phosphate crystal-associated proteins: α2-HS-glycoprotein, prothrombin F1, and osteopontin. Mol Urol 4: 383PubMed
8.
Umekawa T, Kurita T (1994) Calprotectin-like protein is related to soluble organic matrix in calcium oxalate urinary stone. Biochem Mol Biol Int 34: 309PubMed
9.
Bennett J, Dretler S, Selengut J, Orme-Johnson W (1994) Identification of the calcium-binding protein calgranulin in the matrix of struvite stones. J Endourol 8: 95PubMed
10.
Tawada T, Fujita K, Sakakura T, Shibutani T, Nagata T, Iguchi M, Kohri K (1999) Distribution of osteopontin and calprotectin as matrix protein in calcium-containing stone. Urol Res 27: 238CrossRefPubMed
11.
Prowse C, Esnouf M (1977) The isolation of a new warfarin-sensitive protein from bovine plasma. Biochem Soc Trans 5: 255PubMed
12.
13.
Miletich J, Broze G (1987) Human plasma protein Z antigen: range in normal subjects and effect of warfarin therapy. Blood 69: 1580PubMed
14.
Sejima H, Hayashi T, Deyashiki Y, Nishioka J, Suzuki K (1990) Primary structure of vitamin K-dependent human protein Z. Biochem Biophys Res Commun 171: 661CrossRefPubMed
15.
Fujimaki K, Yamazaki T, Taniwaki M, Ichinose A (1998) The gene for human protein Z is localized to chromosome 13 at band q34 and is coded by eight regular exons and one alternative exon. Biochemistry 37: 6838CrossRefPubMed
16.
Ravi S, Mauron T, Lammle B, Wuillemin W (1998) Protein Z in healthy human individuals and in patients with a bleeding tendency. J Haematol 102: 1219CrossRef
17.
Kaneko K, Yamanobe T, Nakagomi K, Mawatari K, Onoda M, Fujimori S (2004) Detection of protein Z in a renal calculus composed of calcium oxalate monohydrate with the use of LC-MS/MS following 2D-PAGE separation. Anal Biochem 324: 191CrossRefPubMed
18.
Rost S, Fregin A, Koch D, Compes M, Muller C, Oldenburg J (2004) Compound heterozygous mutations in the gamma-glutamyl carboxylase gene cause combined deficiency of all vitamin K-dependent blood coagulation factors. Br J Haematol 126: 546CrossRefPubMed
19.
Vossen C, Hasstedt S, Rosendaal F, Callas P, Bauer K, Broze G, Hoogendoorn H, Long G, Scott B, Bovill E (2004) Heritability of plasma concentrations of clotting factors and measures of a prethrombotic state in a protein C-deficient family. J Thromb Haemost 2: 242CrossRefPubMed
20.
Gorg A, Postel W, Gunther S (1988) The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 9: 531CrossRefPubMed
21.
Eng J, McCormack A, Yates J (1994) An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J Am Soc Mass Spectrom 5: 976CrossRef
22.
Kawakami T, Nagata T, Muraguchi A, Nishimura T (2000) Alteration of protein composition in mouse thymocytes by signals through T-cell receptor. Electrophoresis 21: 1846CrossRefPubMed
23.
Figeys D (2003) Proteomics in 2002: a year of technical development and wide-ranging application. Anal Chem 75: 2892CrossRef
24.
Lin D, Tabb D, Yates J III (2003) Large-scale protein identification using mass spectrometry. Biochim Biophys Acta 1646: 1PubMed
25.
Kaneko K, Fujimori S, Kamatani N, Yamanaka H, Yamaoka N, Akaoka I (1997) Microanalysis of pathological crystals and urinary calculi. Adv Exp Med Biol 431: 41
26.
Kaneko K, Maru M (2000) Determination of urate crystal formation using flow cytometry and micro area X-ray diffractometry. Anal Biochem 281: 9CrossRefPubMed
27.
Kaneko K, Fujimori S, Ito H, Nakayama Y, Oyama H, Kanbayashi T, Miyashita H, Akaoka I (1988)Renal handling of hypoxanthine and xanthine in normal subjects and in four cases of idiopathic renal hypouricemia. J Rheumatol 15: 325PubMed
28.
Shevchenko A, Wilm M, Vorm O, Mann M (1996) Mass spectrometric sequencing of proteins from silver-stained polyacrylamide gels. Anal Chem 68: 850CrossRefPubMed
29.
Bleasby A, Akrigg D, Attwood T (1994) OWL-A non-redundant composite protein sequence database. Nucleic Acids Res 22: 3574PubMed
30.
Campopiano D, Clarke D, Polfer N, Barran P, Langley R (2004) Structure-activity relationships in defensin dimers. A novel link between beta-defensin tertiary structure and antimicrobial activity. J Biol Chem (2004) 279: 48671
31.
Ganz T (2004) Defensins: antimicrobial peptides of vertebrates. C R Biol 327: 539PubMed
32.
Ozasa H, Suzuki T, Takahashi K, Ota K (1989) Protein components of amyloid-like kidney stones of chronic hemodialysis patients. Nephron 53: 257PubMed
33.
Barak M, Ginesin Y, Hornstein L, Levin R, Gruener N (1990) Excretion of urinary protein induced by extracorporeal piezoelectric lithotripsy. Br J Urol 66: 575PubMed
Metadata
Title
Analysis of urinary calculi obtained from a patient with idiopathic hypouricemia using micro area x-ray diffractometry and LC-MS
Authors
Kiyoko Kaneko
Tomoyo Yamanobe
Maki Onoda
Ken-ichi Mawatari
Kazuya Nakagomi
Shin Fujimori
Publication date
01-12-2005
Publisher
Springer-Verlag
Published in
Urolithiasis / Issue 6/2005
Print ISSN: 2194-7228
Electronic ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-005-0480-8

Other articles of this Issue 6/2005

Urolithiasis 6/2005 Go to the issue

Original Paper

Changes in the urine composition during its passage through the ureter. A concept of urothelial function

Original Paper

The use of tamsulosin in the medical treatment of ureteral calculi: where do we stand?

Letter to the Editor

Viewing windows do not alter Hounsfield units in CT scans

Original Paper

Ultracal-30 gypsum artificial stones for research on the mechanisms of stone breakage in shock wave lithotripsy

Original Paper

The potency of KUL-7211, a selective ureteral relaxant, in isolated canine ureter: comparison with various spasmolytics

Original Paper

An animal model of calcium oxalate urolithiasis based on a cyclooxygenase 2 selective inhibitor